Myosclerosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:289380OMIM:255600G71.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Myosclerosis, also known as hereditary myosclerosis or myosclerosis congenita, is an extremely rare inherited muscle disorder. In this condition, the muscles throughout the body gradually become stiff and hard due to the buildup of fibrous (scar-like) tissue within the muscles. This process is sometimes called "muscle sclerosis," meaning the muscles become rigid and lose their normal flexibility. The disease typically begins in early childhood. Children may first notice tightness in their muscles, especially in the legs and trunk. Over time, the stiffness spreads to other muscles, leading to limited joint movement (contractures) and difficulty walking. The muscles themselves may not be obviously weak at first, but the stiffness makes it very hard to move normally. Affected individuals often develop a stiff, slow walking pattern and may eventually need mobility aids. Myosclerosis is caused by mutations in the COL6A2 gene, which provides instructions for making a type of collagen — a protein that supports the structure of muscles and connective tissue. Because this condition is so rare, treatment options are limited and mainly focus on managing symptoms. Physical therapy, stretching exercises, and sometimes surgery for severe joint contractures are the main approaches. There is currently no cure or disease-modifying treatment available. Research into collagen-related muscle diseases continues, offering hope for future therapies.

Also known as:

Key symptoms:

Progressive muscle stiffnessLimited joint movement (contractures)Stiff or slow walking patternDifficulty bending or stretching musclesTightness in the legs and trunkReduced range of motion in arms and legsToe walkingMild muscle weaknessDifficulty with physical activities like running or climbing stairsRigid spine or limited neck movementMuscles that feel unusually firm or hard to the touch

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Myosclerosis.

View clinical trials →

No actively recruiting trials found for Myosclerosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Myosclerosis community →

No specialists are currently listed for Myosclerosis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Myosclerosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open MyosclerosisForum →

No community posts yet. Be the first to share your experience with Myosclerosis.

Start the conversation →

Latest news about Myosclerosis

No recent news articles for Myosclerosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How severe is the muscle fibrosis currently, and what is the expected rate of progression?,What physical therapy program do you recommend, and how often should sessions occur?,Should we monitor breathing function, and if so, how often?,Are there any clinical trials or research studies we could participate in?,What signs should prompt us to seek urgent medical attention?,Are other family members at risk, and should they be tested?,What assistive devices or home modifications would you recommend at this stage?

Common questions about Myosclerosis

What is Myosclerosis?

Myosclerosis, also known as hereditary myosclerosis or myosclerosis congenita, is an extremely rare inherited muscle disorder. In this condition, the muscles throughout the body gradually become stiff and hard due to the buildup of fibrous (scar-like) tissue within the muscles. This process is sometimes called "muscle sclerosis," meaning the muscles become rigid and lose their normal flexibility. The disease typically begins in early childhood. Children may first notice tightness in their muscles, especially in the legs and trunk. Over time, the stiffness spreads to other muscles, leading to

How is Myosclerosis inherited?

Myosclerosis follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Myosclerosis typically begin?

Typical onset of Myosclerosis is childhood. Age of onset can vary across affected individuals.